Closing the Generation Gap: Part 2 - Hemophilia Federation of America
Por un escritor de hombre misterioso
Descripción
Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder. Part 1 was a great […]
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->
A practical approach for adoption of a hub and spoke model for cell and gene therapies in low- and middle-income countries: framework and case studies
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions – DrugPatentWatch - Make Better Decisions
Haemophilia Nature Reviews Disease Primers
Upcoming Events — The Coalition for Hemophilia B
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial - The Lancet Haematology
Community Calendar
Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years - The Lancet Haematology
Emicizumab offers 'new path forward' for infants with severe hemophilia A
Women's Health and Education Center (WHEC) - Rare Clotting Factor Deficiencies
Current Rare Hub Partners - EveryLife Foundation for Rare Diseases
PDF) Costs and utilization of treatment in patients with hemophilia
Great challenges in hemophilia
de
por adulto (el precio varía según el tamaño del grupo)